Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Economics, Business, Accounting & Society Review Jurnal Ekonomi Bisnis Manajemen dan Akuntansi (Jebisma)
Sarini, Anggun
Unknown Affiliation
Economics, Econometrics & Finance Social Sciences

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
DETERMINANTS OF TAX AVOIDANCE SCHEME IN MANUFACTURING SECTOR IN THE PHARMACEUTICA SECTOR LISTEDIN THE BEI LIST DURING THE PERIOD 2019-2023: Universitas Islam Indonesia Sarini, Anggun
Jurnal Ekonomi Bisnis Manajemen dan Akuntansi (JEBISMA) Vol 2 No 3 (2025): April 2025
Publisher : PT. Media Edutama Nusantara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70197/jebisma.v2i3.75

Abstract

Penelitian ini bertujuan untuk menganalisis pengaruh ukuran perusahaan, intangible asset dan tunneling incentive terhadap penghindaran pajak (tax avoidance), penelitian ini dilakukan pada perusahaan manufaktur di sektor farmasi yang terdaftar di Bursa Efek Indonesia tahun 2019-2023. Populasi penelitian mencakup perusahaan manufaktur sub sektor makanan dan minuman yang terdaftar di BEI pada periode tersebut, yang sebagian besar juga tergolong dalam skala perusahaan multinasional. Penentuan sampel dalam penelitian ini yaitu dengan purposive sampling. Berdasarkan teknik puposive sampling didapatkan sampel sebanyak 40 sampel atas 8 perusahaan selama 5 tahun. Data yang digunakan adalah data sekunder berupa laporan keuangan. Hasil penelitian ini menunjukkan Penelitian ini menunjukkan bahwa variabel ukuran perusahaan intangible asset dan tunneling incentive tidak memiliki pengaruh yang signifikan terhadap penghindaran pajak (tax avoidance).
Tax Planning or Profit Shifting? Investigating the Drivers of Transfer Pricing in Indonesia's Pharmaceutical Sector Sarini, Anggun; Muhammad, Rifqi
Economics, Business, Accounting & Society Review Vol. 4 No. 1 (2025): Economics, Business, Accounting & Society Review
Publisher : International Ecsis Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55980/ebasr.v4i1.177

Abstract

This study investigates the firm-level determinants of transfer pricing practices within Indonesia’s pharmaceutical sector, an industry marked by high intangible asset intensity and regulatory sensitivity. Using panel data from eight publicly listed pharmaceutical companies on the Indonesia Stock Exchange (IDX) for the 2019–2023 period, the research employs a Random Effect Model to assess the impact of tax ratio, firm size, intangible assets, and tunneling incentive on transfer pricing decisions. The findings reveal that the tax ratio is the only variable that has a statistically significant and positive impact on transfer pricing, confirming the theory that higher tax burdens encourage firms to shift profits through intra-group transactions. In contrast, firm size, intangible assets, and tunneling incentives exhibit no significant effects, indicating that structural characteristics alone may not fully explain transfer pricing behavior in emerging markets. This study enriches the discourse on agency theory and positive accounting theory by highlighting how managerial decisions are primarily influenced by fiscal constraints rather than firm complexity or ownership motives. It challenges widely held assumptions that larger firms or those with higher intangible assets are more prone to transfer pricing, especially in contexts with growing regulatory enforcement such as Indonesia. The results underscore the importance of risk-based tax auditing strategies that target firms with high tax exposure, rather than relying solely on observable characteristics like size or asset structure.
Co-Authors Rifqi Muhammad